Erbitux 500mg Bottle Of 100ml Solution For Infusion

Erbitux solution for infusion is an anticancer medication containing cetuximab as the active ingredient. It is used to treat certain types of cancer, including head and neck cancer as well as colorectal cancer. It works by helping the immune system identify and destroy cancer cells.

Common side effects include nausea, headache, vomiting, and skin rash. If these symptoms persist or worsen, consult your doctor, and seek immediate medical attention if you experience difficulty breathing, fever, or chills. Regular blood tests are required to monitor your blood cell counts, heart health, liver function, and electrolyte levels.

Erbitux solution for infusion may increase your skin's sensitivity to sunlight, so take precautions to protect your skin from sun exposure. Before starting treatment, inform your doctor of any pre-existing heart or kidney conditions and provide a list of all current medications, as Erbitux solution for infusion can interact with many medicines.

Dosage

Overdose

This medicine is given by healthcare professionals so it is unlikely that you will be given too much medicine. If you think you have been given too much medicine, tell your doctor. You may experience side effects if you have been injected with too much medicine.

Missed a Dose

This medicine is given by a healthcare professional so it is unlikely that you will be missing the dose of medicine. If a dose is missed you can talk to your doctor. However, if it is nearly time for the next dose, skip the missed dose. Do not take a double dose to make up for a forgotten dose.

Mode of Action

How Does It Work?

Cetuximab is a targeted cancer therapy that works by binding to the epidermal growth factor receptor (EGFR) on the surface of cancer cells. This blocks the signals that promote cell growth and survival, leading to slowed or stopped cancer cell growth. Cetuximab can trigger the immune system to attack cancer cells and reduce the number of EGFR receptors on the cell surface.

Directions for Use

This medicine will be given to you by your doctor or nurse. Self-administration is not advised.

Precautions and Warnings

Pregnancy

Can I be given Erbitux solution for infusion during pregnancy?

Limited information is available on the safety of this medicine during pregnancy. You should not use this medicine if you are pregnant unless your doctor advises you.

Breast Feeding

Can I be given Erbitux solution for infusion while breastfeeding?

Breastfeeding is not recommended during treatment with Erbitux solution for infusion and for 2 months after your last dose. It is unknown if Erbitux solution for infusion passes into breast milk.

Driving

Can I drive if I have been given Erbitux solution for infusion?

It is not known how Erbitux solution for infusion affects your ability to drive or use machinery. If you experience side effects like dizziness or drowsiness during treatment, avoid driving or operating machinery until these symptoms improve.

Alcohol

Can I consume alcohol with Erbitux solution for infusion?

Alcohol is not known to interact with this medicine. However, if you consume alcohol too often discuss it with your doctor.

Other General Warnings

Talk to your doctor if

• You have a history of allergy to red meat or tick bites, or you test positive for IgE antibodies against cetuximab (α-1-3-galactose), which puts you at a higher risk of anaphylactic reactions.
• You have pre-existing cardio-pulmonary diseases or reduced performance status
• You have experienced symptoms like dyspnoea, cough, or fever, which could indicate interstitial lung disease (ILD).
• You have progressively decreased serum magnesium, potassium, or calcium levels, necessitating regular monitoring and electrolyte repletion during cetuximab therapy.
• You have developed severe neutropenia or related infectious complications, especially when cetuximab is combined with platinum-based chemotherapy.
• You have cardiovascular conditions or are at risk of severe cardiovascular events, particularly if you are aged 65 years or older or have a compromised performance status.
• You have symptoms of keratitis, such as eye inflammation, blurred vision, or lacrimation. If ulcerative keratitis is diagnosed, cetuximab should be discontinued.

Contraindications

• If you have any allergy to cetuximab or any other ingredient of this medicine.
• Erbitux solution for infusion (cetuximab) should not be used with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer (mCRC) who have RAS mutations or whose RAS status is unknown.

Side effects

• Hypomagnesaemia (magnesium deficiency)
• Increase in liver enzyme levels
• Skin reactions
• Dehydration
• Headache
• Conjunctivitis
• Diarrhoea; nausea; vomiting

Interactions

Interactions with other medicines

• Cetuximab, when combined with other medications, can increase the risk of certain side effects.
• With platinum-based chemotherapy: Higher risk of severe low blood cell counts (leukopenia, neutropenia), leading to infections like febrile neutropenia, pneumonia, and sepsis.
• With fluoropyrimidines: Increased risk of heart problems (ischemia, heart failure) and hand-foot syndrome (redness, swelling, and pain in the palms and soles of the feet).
• With capecitabine and oxaliplatin (XELOX): Increased risk of severe diarrhea.

Storage and disposal

Store Erbitux solution for infusion in the refrigerator between (2°C to 8°C) in its original carton.